Long Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) shares fell roughly 8% on Friday following an update from Aetna (NYSE:AET) regarding the insurer’s coverage of QCOR’s lead product, H.P. Acthar … Continue Reading
Read NowMost Popular - On Monday, we wrote that MethylGene, a relative unknown in the industry, is poised to climb after a recent financing. While the stock remains flat … Continue Reading
Read NowLong Ideas - On Tuesday morning, NuPathe Inc. (NASDAQ:PATH) announced the receipt of an $8.5M term loan, just a month after the company firmed up the balance sheet … Continue Reading
Read NowMost Popular - Between Keryx and its Japanese partner JT Torii, four clinical trials for lead candidate Zerenex are set to report data over the coming months. The … Continue Reading
Read NowMost Popular - Weight-loss drug makers popped Wednesday morning after mega-insurer Aetna (NYSE:AET) issued a bulletin on weight reduction medications and procedures. Qysmia, from Vivus (NASDAQ:VVUS), and Arena’s … Continue Reading
Read NowMost Popular - We offered some insight this week into how social media can drive the markets. Jason Napodano noted recent performance from SRPT, and discussed what patient-investor … Continue Reading
Read NowMost Popular - While shares of Dynavax Technologies (DVAX) were crushed Friday morning due to Thursday’s negative FDA Panel vote on lead candidate Heplisav, additional downside on the … Continue Reading
Read Now